DJIA 17,865.93 38.18 0.21%
NASDAQ 4,802.13 14.81 0.31%
S&P 500 2,070.09 -2.74 -0.13%
market minute promo

145.25 0.52 (0.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $145.25 0.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $145.97
Previous Close $144.73
Daily Range $144.73 - $146.55
52-Week Range $105.17 - $153.10
Market Cap $48.8B
P/E Ratio 93.98
Dividend (Yield) $0.00 (0.0%)
Volume 725,621
Average Daily Volume 2,674,152
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

George Soros Just Bought These 3 Stocks: Should You?

Controversial billionaire George Soros purchased large stakes in AbbVie, Actavis plc, and Valeant Pharmaceuticals in the third-quarter. Should you follow in his footsteps?

Bio Blast Pharma (ORPN) in Focus: Stock Moves Up 26.6% - Tale of the Tape

Valeant Pharmaceuticals International (VRX) Showing Signs Of Being A Momo Momentum Stock

NPS Pharmaceuticals' SBS Drug Gets Orphan Drug Status - Analyst Blog

NPS Pharmaceuticals' SBS Drug Gets Orphan Drug Status - Analyst Blog

Ariad Pharmaceuticals (ARIA) Jumps: Stock Gains 9.7% - Tale of the Tape

Today's Stocks Driving Success For The Drugs Industry

Valeant May Actually Be A Good Investment Right Now

Shire to Relocate Employees Under One Shire Program - Analyst Blog

Synergy Pharmaceuticals Drug Fares Well in Phase II Study - Analyst Blog

Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog

Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $145.25 (0.36%)
Current stock: VRX
JNJ $108.34 (1.05%)
Current stock: JNJ
PFE $31.17 (0.21%)
Current stock: PFE
NVS $96.61 (1.10%)
Current stock: NVS